Synergy Pharmaceuticals Inc. Overview
Company Headquarter: New York, US
Founded: 2005
Workforce: 155+ employees
Company Working: Synergy Pharmaceuticals Inc. is a biopharmaceutical company which focuses on the development and commercialization of novel gastrointestinal therapies. The company holds 100% worldwide rights to the proprietary uroguanylin based GI platform that includes one commercial product, TRULANCE (plecanatide), and a second lead product candidate, dolcanatide.



